2014
DOI: 10.3109/21678421.2014.964259
|View full text |Cite
|
Sign up to set email alerts
|

Modification of the association between lead exposure and amyotrophic lateral sclerosis by iron and oxidative stress related gene polymorphisms

Abstract: Objective To examine whether functional polymorphisms in hemochromatosis (HFE; H63D and C282Y), transferrin (TfC2), and glutathione-s-transferase Pi1 (GSTP1; Ile105Val) genes modify any lead-ALS association. Methods We measured blood lead using atomic absorption spectroscopy and bone lead—a biomarker of cumulative lead exposure—using K-shell-X-ray fluorescence in 100 neurologist-confirmed ALS cases and 194 controls, the latter recruited as part of two separate studies; all subjects lived in New England. Part… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
23
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(24 citation statements)
references
References 34 publications
1
23
0
Order By: Relevance
“…The hemochromatosis gene encodes a protein that is in part responsible for iron sensing and regulation and HFE variant homozygosity results in clinical hemochromatosis, which is characterized by iron overload. The presence of one or more polymorphism of the HFE gene (either H63D or C282Y) has been shown to exacerbate the detrimental effects of lead on cognitive function in elderly men (Wang et al, 2007), and has been associated with increased susceptibility to neurodegenerative disease (Eum et al, 2014, Mariani et al, 2013, Nandar and Connor, 2011). Interestingly, variant HFE gene expression has also been associated with lower blood and bone lead in the NAS cohort (Wright et al, 2004).…”
Section: Introductionmentioning
confidence: 99%
“…The hemochromatosis gene encodes a protein that is in part responsible for iron sensing and regulation and HFE variant homozygosity results in clinical hemochromatosis, which is characterized by iron overload. The presence of one or more polymorphism of the HFE gene (either H63D or C282Y) has been shown to exacerbate the detrimental effects of lead on cognitive function in elderly men (Wang et al, 2007), and has been associated with increased susceptibility to neurodegenerative disease (Eum et al, 2014, Mariani et al, 2013, Nandar and Connor, 2011). Interestingly, variant HFE gene expression has also been associated with lower blood and bone lead in the NAS cohort (Wright et al, 2004).…”
Section: Introductionmentioning
confidence: 99%
“…Multiple lines of evidence suggest that lead exposure plays a significant role in the aetiology of MND. These lines of evidence include the meta-analysis between MND and occupational lead exposure [ 11 ], previous bone lead studies [ 23 , 24 , 25 , 26 ] and studies that have found positive associations between MND and lead in human biological samples [ 13 , 14 , 16 ], questionnaires [ 12 , 20 , 21 , 22 ] and the results from this study. Lead is also known to cause oxidative stress [ 69 , 70 ].…”
Section: Discussionmentioning
confidence: 64%
“…Eum et al (2015) [ 26 ] measured bone lead, a biomarker of cumulative lead exposure, using K-shell-X-ray fluorescence in 100 neurologist-confirmed MND cases and 194 controls. They further examined the interaction with haemachromatosis genotype and found that the OR per 15.6 μg/g patella lead (interquartile range—IQR) was 8.24 (95% CI = 0.94–72.19) times larger among C282Y variant carriers, and 0.34 (95% CI = 0.15–0.78) times smaller among H63D variant carriers; results however were weaker for tibia lead.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, H63D was noted to affect patella and tibia lead levels, associated with ALS. Specifically, in sALS patients, C282Y was associated with patella and tibia lead levels, while GSTP1 was related to blood lead levels (Eum et al, 2015). Additionally, there is strong evidence that H63D polymorphism has a protective role against AD risk (Lin et al, 2012), while there is only mild indication that the C282Y polymorphism protects against PD (Duan et al, 2016;Xia et al, 2015).…”
Section: Sod1 Hfe Transferrin Gsts Pgc-1α and Nrf2mentioning
confidence: 99%